what they said (Hover the mouse cursor over underlined words for more info)

An osteoporosis drug is as effective at preventing breast cancer as the commonly used tamoxifen, cutting in half the likelihood of cancer among high-risk women while causing fewer side effects, new research shows.
The results of a large continent-wide study, released yesterday, show that older high-risk women using raloxifene were statistically no more likely to get breast cancer than women taking tamoxifen.
"Women's greatest fear in life oftentimes is breast cancer and this gives women another option," said Lavina Lickley, the principal Canadian investigator of the study and a women who has herself battled breast cancer.
"For postmenopausal women, obviously it's not approved for use at the moment, but I think it will be very quickly," added Dr. Lickley, a surgeon at Women's College Hospital in Toronto. "On balance, it's the logical choice."....

The original article can found in the Media Doctor archives.

how did it rate? (more information)

what we said (Hover the mouse cursor over underlined words for more info)

See comments from the other two rated stories on this trial.

public forum

voice your opinion in the forum

• All comments and feedback submitted to Media Doctor are subject to editorial approval before being made viewable by the public. It may take up to a week for your comments to be approved. Additionally, no response will be given to questions posed in public comments. Media Doctor does not provide medical advice, or answers to medical questions posed by the public.
• If you provide your email address it will not be displayed to the general public.
• Comments may be edited by Media Doctor to remove defamatory or sensitive statements, and brand names.
• Required fields are marked with an asterisk (*).